×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
概要
This Program will be conducted only in Japanese. No interpretation will be available.
We look forward to welcoming you at Nihonbashi Life Science HUB on June 18, 2018 for stimulating discussion!
プログラム委員会
-
Noriko Katori, PhD Division of Drugs
National Institute of Health Sciences, Japan -
Takeshi Hamaura, PhD Head of Pharmaceutical Technology Division
Daiichi Sankyo Co., Ltd., Japan -
Yukio Hiyama, PhD Visiting Researcher
National Institute of Health Sciences, Japan -
Fusashi Ishikawa, PhD, MSc Associate Biopharmaceutics Research Fellow, Formulation R&D Laboratories
Sumitomo Dainippon Pharma Co., Ltd., Japan -
Yoshihiro Matsuda, PhD Senior Scientist (for Quality), Pharmacist
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Tomonori Nakagawa Production HQ Manufacturing Process Development Department (API)
Otsuka Pharmaceutical Co., Ltd., Japan -
Haruhiro Okuda, PhD Deputy Director General
National Institute of Health Sciences, Japan -
Tomoaki Sakamoto, PhD Section Chief, Division of Drugs
National Institute of Health Sciences, Japan -
Kazunori Takagi, PhD Deputy Review Director, Office of Generic Drugs
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Jun Yamada Senior Manager, Global CMC NCE-Japan & East Asia
Pfizer Japan Inc., Japan
